Literature DB >> 2844225

Deoxycytidine kinase from human leukemic spleen: preparation and characteristics of homogeneous enzyme.

C Bohman1, S Eriksson.   

Abstract

Deoxycytidine kinase from human leukemic spleen has been purified 6000-fold to apparent homogeneity with an overall yield of 10%. The purification was achieved by using DEAE chromatography, hydroxylapatite chromatography, and affinity chromatography on dTTP-Sepharose. Only one form of deoxycytidine kinase activity was found during all the chromatographic procedures. The subunit molecular mass, as judged by sodium dodecyl sulfate--polyacrylamide gel electrophoresis, was 30 kilodaltons. The pure enzyme phosphorylates deoxycytidine, deoxyadenosine, and deoxyguanosine, demonstrating for the first time that the same enzyme molecule has the capacity to use these three nucleosides as substrates. The apparent molecular weight of the active enzyme, determined by gel filtration and glycerol gradient centrifugation, was 60,000. Thus, the active form of human deoxycytidine kinase is a dimer. The kinetic behavior of pure human deoxycytidine kinase was studied in detail with regard to four different phosphate acceptors and two different phosphate donors. The apparent Km values were 1, 20, 150, and 120 microM for deoxycytidine, arabinosylcytosine, deoxyguanosine, and deoxyadenosine, respectively. The Vmax values were 5-fold higher for the purine nucleosides as compared to the pyrimidine substrates. We observe competitive inhibition of the phosphorylation of one substrate by the presence of either of the three other substrates, but the apparent Ki values differed greatly from the corresponding Km values, suggesting the existence of allosteric effects. The double-reciprocal plots for ATP-MgCl2 as phosphate donor were convex, indicating negative cooperative effects. In contrast, plots with varying dTTP-MgCl2 concentration as phosphate donor were linear with an apparent Km of 2 microM. The enzyme activity was strongly inhibited by dCTP, in a noncompetitive way with deoxycytidine and in a competitive way with ATP-MgCl2.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844225     DOI: 10.1021/bi00412a009

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Cloning and characterization of full-length mouse thymidine kinase 2: the N-terminal sequence directs import of the precursor protein into mitochondria.

Authors:  L Wang; S Eriksson
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  Cloning and expression of human deoxyguanosine kinase cDNA.

Authors:  M Johansson; A Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

3.  6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virus.

Authors:  D R Averett; G W Koszalka; J A Fyfe; G B Roberts; D J Purifoy; T A Krenitsky
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

4.  Direct photoaffinity-labelling of human deoxycytidine kinase with the feedback inhibitor dCTP.

Authors:  O Jansson; S Eriksson
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

5.  Quantitation of synergism of arabinosylcytosine and cladribine against the growth of arabinosylcytosine-resistant human lymphoid cells.

Authors:  Tieran Han; Marilyn Fernandez; Ting-Chao Chou; Ram P Agarwal
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

6.  Mosquito has a single multisubstrate deoxyribonucleoside kinase characterized by unique substrate specificity.

Authors:  Wolfgang Knecht; Gitte Ebert Petersen; Michael Paolo Bastner Sandrini; Leif Søndergaard; Birgitte Munch-Petersen; Jure Piskur
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

7.  Deoxycytidine kinase and deoxyguanosine kinase of Lactobacillus acidophilus R-26 are colinear products of a single gene.

Authors:  N Ma; S Ikeda; S Guo; A Fieno; I Park; S Grimme; T Ikeda; D H Ives
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

8.  Erk5 contributes to maintaining the balance of cellular nucleotide levels and erythropoiesis.

Authors:  Maria Angulo-Ibáñez; Xavier Rovira-Clavé; Alba Granados-Jaén; Bradley Downs; Yeong C Kim; San Ming Wang; Manuel Reina; Enric Espel
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

9.  Kinetic properties of mutant deoxyguanosine kinase in a case of reversible hepatic mtDNA depletion.

Authors:  Bénédicte Mousson de Camaret; Jan-Willem Taanman; Sylvie Padet; Maïté Chassagne; Martine Mayençon; Pascale Clerc-Renaud; Ginette Mandon; Marie-Thérèse Zabot; Alain Lachaux; Dominique Bozon
Journal:  Biochem J       Date:  2007-03-01       Impact factor: 3.857

10.  Characterization of the deoxycytidine kinase promoter in human lymphoblast cell lines.

Authors:  E H Chen; E E Johnson; S M Vetter; B S Mitchell
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.